Epivir-HBV + Plus HBIG Response to an Experimental HBV Vaccine Permits Withdrawal of HBIG Prophylaxis in HBV-infected Liver Graft Recipients - 10/03/05 Combination Prophylaxis in HBV-positive Liver Transplant Recipients with YMDD Mutants Prevents Hepatitis Recurrence - 2/09/05 Low-dose Hepatitis B Immune Globulin (HBIG) and Higher-dose Lamivudine Combination Prevents HBV Recurrence After Liver Transplantation - 1/21/05 Outcomes in Liver Transplant Recipients with Hepatitis B Virus: Resistance and Recurrence - 12/01/04 Lamivudine Prophylaxis with Adefovir Salvage Therapy in Hepatitis B Patients Undergoing Liver Transplant Is More Cost Effective Than Combination Treatment with Lamivudine Plus HBIG 11/01/04
